The impact of HIF1α on the Per2 circadian rhythm in renal cancer cell lines

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Okabe, Takashi ^a   Kumagai, Megumi ^b,c   Nakajima, Yoshihiro ^d   Shirotake, Suguru ^a   Kodaira, Kiichiro ^a   Oyama, Masafumi ^a   Ueno, Munehisa ^a   Ikeda, Masaaki ^b,c  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Research Center for Genomic Medicine   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PER2 PROTEIN; CIRCADIAN RHYTHM SIGNALING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; CAKI 2 CELL; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RENAL CANCER CELL LINE; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; GENE VECTOR; GENETIC TRANSCRIPTION; GENETICS; KIDNEY TUMOR; METABOLISM; MOUSE; PATHOLOGY; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASE SEQUENCE; CELL LINE, TUMOR; CIRCADIAN RHYTHM; GENES, REPORTER; GENETIC VECTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; MICE; MICE, INBRED C57BL; NIH 3T3 CELLS; PERIOD CIRCADIAN PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84908162862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109693     Document Type: Article

References (37)

1. McLaughlin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27: 115-123.
2. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, et al. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157: 411-421.
3. Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, et al. (2007) Renal cancer cells lacking hypoxia inducible factor (HIF)-1a expression maintain vascular endothelial growth factor expression through HIF-2a. Carcinogenesis 3: 529-536.
4. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778.
5. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
6. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
7. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
8. Thelen P, Hemmerlein B, Kugler A, Seiler T, Ozisik R, et al. (1999) Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma. Anticancer Res 19: 1563-1565.
9. Panda S, Hogenesch JB, Kay SA (2002) Circadian rhythms from flies to human. Nature 417: 329-335.
10. Reppert SM, Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418: 935-941.
11. Reppert SM, Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63: 647-676.
12. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, et al. (1998) Role of the CLOCK protein in the mammalian circadian mechanism. Science 280: 1564-1569.
13. Griffin EA Jr, Staknis D, Weitz CJ (1999) Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. Science 286: 768-771.
14. Wilkins AK, Barton PI, Tidor B (2007) The Per2 negative feedback loop sets the period in the mammalian circadian clock mechanism. PLOS Comput Biol 3: e242. Available: http://www.ploscompbiol.org/article/info%3Adoi%2F10. 1371%2Fjournal.pcbi.0030242.
15. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, et al. (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26: 1241-1246.
16. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
17. Mazzoccoli G, Piepoli A, Carella M, Panza A, Pazienza V, et al. (2012) Altered expression of the clock gene machinery in kidney cancer patients. Biomed Pharmacother 66: 175-179.
18. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, et al. (2004) Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119: 693-705.
19. Baggs JE, Price TS, DiTacchio L, Panda S, FitzGerald GA, et al. (2009) Network features of the mammalian circadian clock. PLoS Biology 7: e52. Available: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio. 1000052#pbio-1000052-g005.
20. Noguchi T, Ikeda M, Ohmiya Y, Nakajima Y (2012) A dual-color luciferase assay system reveals circadian resetting of cultured fibroblasts by co-cultured adrenal glands. PLoS One 7: e37093. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037093.
21. Yang F, Nakajima Y, Kumagai M, Ohmiya Y, Ikeda M (2009) The molecular mechanism regulating the autonomous circadian expression of Topoisomerase I in NIH3T3 cells. Biochem Biophys Res Commun 380: 22-27.
22. Thomas KA, Burr RL (2008) Circadian research in mothers and infants: how many days of actigraphy data are needed to fit cosinor parameters? J Nurs Meas 16: 201-206.
23. Tamaru T, Hattori M, Ninomiya Y, Kawamura G, Varès G, et al. (2013) ROS stress resets circadian clocks to coordinate pro-survival signals. PLoS One 8: e82006. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371% 2Fjournal.pone.0082006#s2.
24. Akashi M, Ichise T, Mamine T, Takumi T (2006) Molecular mechanism of cellautonomous circadian gene expression of Period2, a crucial regulator of the mammalian circadian clock. Mol Biol Cell 17: 555-565.
25. Kong D, Park EJ, Stephen AG, Calvani M, Cardellina JH, et al. (2005) Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNAbinding activity. Cancer Res 65: 9047-9055.
26. Kanaya K, Kamitani T (2003) pVHL-independent ubiquitination of Hif1a and its stabilization by cobalt ion. Biochem Biophys Res Commun 306: 750-755.
27. Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia inducible factor-a and von Hippel-Lindau protein by direct binding to hypoxia inducible factor-a. J Biol Chem 278: 15911-15916.
28. Fu B, Xue J, Li Z, Shi X, Jiang BH, Fang J (2007) Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1 alpha stability and inhibiting its protein synthesis. Mol Cancer Ther 1: 220-226.
29. Tsuchiya Y, Akashi M, Matsuda M, Goto K, Miyata Y, et al. (2009) Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms. Sci Signal. 2: ra26.
30. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE (2002) Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62: 6770-6778.
31. Rini BI, Jaeger E, Weinberg V, Sein N, Chew K, et al. (2006) Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. BJU Int 98: 756-762.
32. Filipski E, King VM, Li X, Granda TG, Mormont MC, et al. (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94: 690-697.
33. Fu L, Lee CC (2003) The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361.
34. Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41-50.
35. Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP (2007) The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 26: 7916-7920.
36. Hua H, Wang Y, Wan C, Liu Y, Zhu B, et al. (2007) Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 9: 815-818.
37. Antoch MP, Toshkov I, Kuropatwinski KK, Jackson M (2013) Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis. Cell Cycle 12: 3673-3680.